EMREA — Easternmed Real Estate Capital Income Statement
0.000.00%
- €715.95m
- €698.54m
- £21.33m
- 49
- 29
- 25
- 21
Annual income statement for Easternmed Real Estate Capital, fiscal year end - March 31st, GBP millions except per share, conversion factor applied.
2020 December 31st | 2021 September 30th | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 9 M | 6 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 30 | 18.7 | 12.3 | 22.3 | 21.3 |
| Cost of Revenue | |||||
| Gross Profit | 22.1 | 17.1 | 11.1 | 17.9 | 13.9 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 37 | -1.34 | 4.58 | 29.7 | 9.49 |
| Operating Profit | -7.07 | 20.1 | 7.73 | -7.42 | 11.8 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -7.82 | 19.7 | 7.85 | -7.5 | 11.4 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -12.7 | 16 | 6.05 | -10.7 | 8.51 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -12.7 | 16 | 6.05 | -10.7 | 8.51 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -12.7 | 16 | 6.05 | -10.7 | 8.51 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.02 | 0.021 | 0.009 | -0.017 | 0.012 |
| Dividends per Share |